Last $4.90 USD
Change Today 0.00 / 0.00%
Volume 700.0
CLTX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 5:20 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Saul Yedgar Ph.D.

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

73$66,000

Background*

Prof. Saul Yedgar, PhD founded Celsus Therapeutics Plc(formerly Morria Biopharmaceuticals Plc) in 2004 and served as its Chief Scientific Officer from 2005 to December 8, 2013. Prof. Yedgar has developed Morria's proprietary technology and is working on new drug candidates. As Chief Scientific Officer, he benefits Morria with his unparalleled knowledge of the technology involved and his innovative thinking. He continues his work at the Hebrew University in Jerusalem. ...

Read Full Background

Corporate Headquarters*

53 Davies street
London, Greater London W1K 5JH

United Kingdom

Phone: 44 20 3322 1321
Fax: 44 20 3322 1350

Board Members Memberships*

2005-2014
Founder

Education*

Unknown/Other Education
University of California - San Diego
MS
Hebrew University of Jerusalem
PhD 1977
Hebrew University of Jerusalem
BS
Bar-Ilan University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$66,000
Total Calculated Compensation$66,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLTX:US $4.90 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELSUS THERAPEUTICS-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.